Mild cognitive impairment: Believe it or not?

International Review of Psychiatry

Volumn 20, Issue 4, 2008, Pages 357-363

  Allegri, Ricardo F ^a   Glaser, Frank B ^a   Taragano, Fernando E ^a   Buschke, Herman ^b  

^a CEMIC   (Argentina)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; PLACEBO; RIVASTIGMINE; ROFECOXIB;

AGING; ALZHEIMER DISEASE; AMNESIA; CEREBROSPINAL FLUID; CLINICAL TRIAL; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; HIPPOCAMPUS; HUMAN; MEDICAL PRACTICE; MEMORY; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ACTIVITIES OF DAILY LIVING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; COGNITION; COGNITION DISORDERS; DEMENTIA; HUMANS; MEMORY DISORDERS; REPRODUCIBILITY OF RESULTS;

EID: 54249163350     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260802095099     Document Type: Review

References (61)

1. Allegri, R. F., Butman, J., Arizaga, R. L., Machnicki, G., Serrano, C., Taragano, F. E. et al., (2007). Economic impact of dementia in developing countries: An evaluation of costs of Alzheimer-type dementia in Argentina. International Psychogeriatrics, 19, 705-718.
2. Allegri, R. F., Drake, M., Harris, P., Serrano, C. M., & Taragano, F. E. (2005). Intrusions in verbal learning in mild cognitive impairment: Prodromal Alzheimer's disease? Neurology, 65, 165.
3. Allegri, R. F., Sarasola, D., Serrano, C. M., Taragano, F. E., Arizaga, R. L., Butman, J. L. et al., (2006). Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer's disease. Neuropsychiatric Disease and Treatment, 2, 105-110.
4. APA (1994). Diagnostic and Statistical Manual of Mental Disorders. DSM-IV. Washington, DC: American Psychiatric Association.
5. Artero, S., Petersen, R., Touchon, J., & Ritchie, K. (2006). Revised criteria for mild cognitive impairment: Validation within a longitudinal population study. Dementia and Geriatric Cognitive Disorders, 22, 465-470.
6. Belleville, S. (2008). Cognitive training for persons with mild cognitive impairment. International Psychogeriatrics, 20, 57-66.
7. Blackford, R. C., & La Rue, A. (1989). Criteria for diagnosis AAMI: Proposed improvement from the field. Developmental Neuropsychology, 5, 295-306.
8. Brookmeyer, R., Gray, S., & Kawas, C. (1998). Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health, 88, 1337-1342.
9. Buschke, H. (1984). Cued recall in amnesia. Journal of Clinical Neuropsychology, 6, 433-440.
10. Buschke, H., Sliwiski, M. J., Kuslansky, G., & Lipton, R. B. (1997). Diagnosis of early dementia by the Double Memory Test: Encoding specificity improves diagnostic sensitivity and specificity. Neurology, 48, 989-992.
11. Crook, T., Bartus, R. T., Ferris, S. H., Whitehouse, P., Cohen, G. D., & Gershon, S. (1986). Age associated memory impairment: Proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health work group. Developmental Neuropsychology, 2, 261-276.
12. De Carli, Ch. (2003). Mild cognitive impairment: Prevalence, prognosis, aetiology and treatment. Lancet Neurology, 2, 15-21.
13. De Kosky, S. T. & Chertkow, H. M. (2001). Just forgetfulness or onset of Alzheimer's disease? 53rd annual Meeting, American Academy of Neurology, Philadelphia, PA.
14. Dubois, B. (2000). Prodromal Alzheimer0s disease: A more useful concept than mild cognitive impairment? Current Opinion in Neurology, 18, 367-369.
15. Dubois, B., & Albert, M. L. (2004). Amnestic MCI or prodromal Alzheimer's disease? Lancet Neurology, 3, 246-248.
16. Dubois, B., Feldman, H., Jacova, C., DeKosky, S., Barberger-Gateau, P., Cummings, J. L. et al., (2007). Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurology, 6, 734-746.
17. Feldman, H. H., Ferris, S., Winblad, B., Sfikas, N., Mancione, L., & He, Y. (2007). Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the In DDEx study. Lancet Neurology, 6, 501-512.
18. Flicker, C., Ferris, S. H., & Reisberg, B. (1993). A two year longitudinal study of cognitive function in normal aging and Alzheimer0s disease. Journal of Geriatric Psychiatry and Neurology, 6, 84-96.
19. Flicker, C., Ferris, S. H., & Reisberg, B. (1991). Mild cognitive impairment in the elderly: Predictors of dementia. Neurology, 41, 1006-1009.
20. Ganguli, M. (2006). Mild cognitive impairment and the 7 uses of epidemiology. Alzheimer Disease and Associate Disorders, 20, S52-57.
21. Ganguli, M., Dodge, H. H., Shen, C., & De Kosky, S. T. (2004). Mild cognitive impairment, amnestic type: An epidemiological study. Neurology, 63, 115-121.
22. Gauthier, S., Reisberg, B., Zaudig, M., Peretsen, R., Ritchie, K., Broich, K., et al., (2006). International Psychogeriatric Association Expert Conference on mild cognitive impairment. Mild Cognitive Impairment. Lancet, 367, 1262-1270.
23. Gold, M., Wang, D., & Truyen, L. (2003). Galantamine for the treatment of mild cognitive impairment: Two double blind, placebo-controlled studies. International Psychogeriatrics, 15, 259.
24. Graham, J. E., Rockwood, K., Beattie, B. L., Eastwood, R., Gauthier, S., Tuokko, H. et al., (1997). Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet, 349, 1793-1796.
25. Grober, E., & Buschke, H. (1987). Genuine memory deficits in dementia. Developmental Neuropsychology, 3, 13-36.
26. Grober, E., Buschke, H., Crystal, H., Bang, S., & Dresner, R. (1988). Screening for dementia by memory testing. Neurology, 38, 900-903.
27. Hansson, O., Zetterberg, H., Buchhave, P., Minthon, L., & Warkentin, S. (2006). Association between CSF biomarkers and incipient Alzheimer's disease in patients with MCI: A follow-up study. Lancet Neurology, 5, 228-234.
28. Harris, P., Drake, M., & Allegri, R. F. (2001). Deterioro cognitivo leve: En búsqueda de la pre-demencia. Acta Psiquiátrica y Psicológica de América Latina, 47, 11-20.
29. Helmer, C., Pasquier, F., & Dartigues, J. F. (2006). Epidemiology of Alzheimer disease and related disorders. Medecine Sciences (Paris), 22, 288-296.
30. Hughes, C. P., Berg, L., Danziger, W. L., Coben, L. A., & Martin, R. L. (1982). A new clinical scale for staging of dementia. British Journal of Psychiatry, 140, 566-572.
31. Jack Jr, C. R., Petersen, R. C., Xu, Y. C., O'Brien, P. C., Smith, G. E., Ivnik, R. J. et al., (1999). Prediction of AD with MRI based hippocampal volume in mild cognitive impairment. Neurology, 52, 1397-1403.
32. Jelic, V., Kipivelto, M., & Winblad, B. (2006). Clinical trials in mild cognitive impairment: Lessons for the future. Journal of Neurology Neurosurgery and Psychiatry, 77, 429-438.
33. Klunk, W. E., Engler, H., Nordberg, A., Bacskai, B. J., Wang, Y., Price, J. C. et al., (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology, 55, 306-319.
34. Kral, A. V. (1962). Senescent forgetfulness: Benign and malignant. Canadian Medical Association Journal, 86, 257-260.
35. Kral, A. V. (1978). Benign senescent forgetfulness. In R. Katzman, R. D. Terry & K. L. Bick (Eds.), Alzheimer's disease: Senile dementia and related disorders (Aging, Vol. 7; pp. 47-51). New York: Raven Press.
36. Larrieu, S., Letenneur, L., Orgogozo, J., Fabrigoule, C., Amieva, H., Le Carret, N. et al., (2002). Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 59, 1594-1599.
37. Laurent, B., & Anterion, C. T. (2002). Incertitudes et limites du MCI: Apport de la neuropsychologie. Revue Neurologique (Paris), 158, 5S11-5S20.
38. Levy, R. (1994). Ageing-associated decline. Psychogeriatrics, 6, 63-68.
39. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939-944.
40. Morris, J. C. (2006). Mild cognitive impairment is early stage Alzheimer disease - Time to revise diagnostic criteria. Archives of Neurology, 63, 15-16.
41. Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H. et al., (2001). Mild cognitive impairment represents early stage Alzheimer's disease. Archives of Neurology, 58, 397-405.
42. Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256, 183-194.
43. Petersen, R. C. (2007). Mild cognitive impairment: Current research and clinical implications. Seminars in Neurology, 27, 22-31.
44. Petersen, R. C. (2000). Mild cognitive impairment or questionable dementia. Archives of Neurology, 57, 643-644.
45. Petersen, R. C., & Morris, J. C. (2005). Mild cognitive impairment as a clinical entity and treatment target. Archives of Neurology, 62, 1160-1163.
46. Petersen, R. C., Parisi, J. E., Dickson, D. W., Johnson, K. A., Knopman, D. S., Boeve, B. F. et al., (2006). Neuropathology of amnesic mild cognitive impairment. Archives of Neurology, 63, 665-672.
47. Petersen, R. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Schaid, D. J., Thibodeau, S. N. et al., (1995). Apolipoprotein E status as a predictor of development of Alzheimer's disease in memory impaired individuals. Journal of the American Medical Association, 273, 1274-1278.
48. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kolmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56, 303-308.
49. Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., & the Alzheimer's Disease Cooperative Study Group, (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine, 352, 2378-2388.
50. Portet, F., Ousset, P. J., Visser, P. J., Frisoni, G. B., Nobili, F., & Scheltens, P. (2006). Mild cognitive impairment in medical practice: A critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 77, 714-718.
51. Rabins, P. V., Lyketsos, C. G., & Steele, C. (1999). Practical dementia care. New York: Oxford University Press.
52. Reisberg, B., Ferris, S. H., de Leon, M. J., & Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136-1139.
53. Reisberg, B., Ferris, S. H., Kluger, A., Franssen, E., Wegiel, J., & de Leon, M. J. (2008). Mild cognitive impairment (MCI): A historical perspective. International Psychogeriatrics, 20, 18-31.
54. Reisberg, B., & Gauthier, S. (2008). Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. International Psychogeriatrics, 20, 1-16.
55. Ritchie, K., Artero, S., & Touchon, J. (2001). Classification criteria for mild cognitive impairment: A population-based validation study. Neurology, 56, 37-42.
56. Rockwood, K., Chertkow, H., & Feldman, H. H. (2007). Is mild cognitive impairment a valid target of therapy? Canadian Journal of Neurological Sciences, 34, S90-S96.
57. Sarazin, M., Berr, C., De Rotrou, J., Fabrigoule, C., Pasquier, F., Legrain, S. et al., (2007). Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study. Neurology, 69, 1859-1867.
58. Serrano, C. M., Allegri, R. F., Caramelli, P., Taragano, F., & Camera, L. (2007). Deterioro cognitivo leve. Encuesta sobre actitudes de médicos especialistas y generalistas. Medicina (BsAs), 67, 19-25.
59. Whitehouse, P. J., & Brodaty, H. (2006). Mild cognitive impairment. Lancet, 367, 1979.
60. Whitehouse, P. J. (2007). Mild cognitive impairment - A confused concept? Nature, 3, 62-63.
61. Winblad, B., Palmer, K., Kipivelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. O. et al., (2004). Mild cognitive impairment: Beyond controversies, towards a consensus-report of the international Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240-246.